Related Experiment Video
Updated: Jan 2, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
miR-124 Functions As A Melanoma Tumor Suppressor By Targeting RACK1
Congcong Shen1, Hui Hua2, Lixiong Gu1
1Department of Dermatology, Affiliated Hospital of Nantong University, Nantong 226001, People's Republic of China.
Background:
miRNAs are small noncoding RNAs that function as posttranscriptional regulators during development and disease. Aberrant expression of miRNAs has been associated with various types of malignant tumors. Decreased levels of miR-124 have been observed in human cancers. RACK1 is a scaffold protein that acts as an oncogene in various human cancers. The association between miR-124 and RACK1 in melanoma has not been characterized.
Materials And Methods:
Real-time quantitative PCR was used to analyze RACK1 and miR-124 expression in melanoma tissue and cell lines. Dual-Luciferase reporter assay was performed to evaluate the effect of miR-124 inhibition on RACK1 expression. The effects of miR-124 on RACK1 in melanoma cell lines were evaluated using Western blot analysis and immunocytochemical staining. Wound-healing, transwell, and MTT assays, and annexin V-fluorescein isothiocyanate/propidium iodide followed by flow cytometry were used to evaluate the effects of miR-124 on RACK1-mediated proliferation, migration, invasion, and apoptosis of melanoma cells.
Results:
The expression of miR-124 in melanoma tissue was lower than that in normal skin tissue, and the expression of RACK1 was higher in melanoma tissue than that in normal skin tissue. Analysis using Dual-Luciferase reporter assay showed that RACK1 was a direct target of miR-124. Western blot and immunocytochemical staining showed that the expression of RACK1 was significantly inhibited by miR-124 in both A375 and A875 melanoma cells. Furthermore, the results of functional experiments showed that degradation of RACK1 by miR-124 inhibited proliferation, migration, and invasion of melanoma cells, and promoted melanoma cell apoptosis.
Conclusion:
The results suggested that miR-124 affected melanoma cells by directly targeting RACK1. miR-124 and RACK1 may be biomarkers for clinical diagnosis, and prognostic factors of human melanoma. Furthermore, miR-124 and RACK1 may be targets for the treatment of melanoma.
Insights
MicroRNA-124 (miR-124) directly targets RACK1, inhibiting melanoma cell growth and spread. This suggests miR-124 and RACK1 as potential biomarkers and therapeutic targets for melanoma.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key posttranscriptional regulators implicated in various diseases, including cancer.
- Decreased miR-124 levels and elevated RACK1 (a known oncogene) are observed in human cancers, but their specific roles in melanoma remain unclear.
Purpose of the Study:
- To investigate the relationship between miR-124 and RACK1 in melanoma.
- To determine if miR-124 directly targets RACK1 and affects melanoma cell behavior.
Main Methods:
- Quantitative PCR to assess miR-124 and RACK1 expression in melanoma tissues and cell lines.
- Dual-Luciferase reporter assay to confirm RACK1 as a direct miR-124 target.
- Western blot and immunocytochemistry to evaluate RACK1 protein levels.
- Functional assays (wound-healing, transwell, MTT, flow cytometry) to assess proliferation, migration, invasion, and apoptosis.
Main Results:
- Melanoma tissues exhibited lower miR-124 and higher RACK1 expression compared to normal skin.
- miR-124 directly targeted and inhibited RACK1 expression in melanoma cells.
- miR-124 suppressed melanoma cell proliferation, migration, and invasion, while promoting apoptosis.
Conclusions:
- miR-124 exerts anti-melanoma effects by directly targeting RACK1.
- miR-124 and RACK1 show potential as diagnostic biomarkers and prognostic factors for melanoma.
- Targeting the miR-124/RACK1 axis presents a promising therapeutic strategy for melanoma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
MAPK Signaling Cascades
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

